New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers stimulate gene that enhances CAR T-cell treatments for solid tumors

Researchers stimulate gene that enhances CAR T-cell treatments for solid tumors

byPeter MacCallum Cancer CentreFOX1-ADA overexpression enhances CAR T cell polyfunctionality. a, Schematic of tumor cell coculture assay. b, IFNγ and TNF production following each round of E0771
Oncology April 28,2024
Researchers stimulate gene that enhances CAR T-cell treatments for solid tumors

Researchers stimulate gene that enhances CAR T-cell treatments for solid tumors

byPeter MacCallum Cancer CentreFOX1-ADA overexpression enhances CAR T cell polyfunctionality. a, Schematic of tumor cell coculture assay. b, IFNγ and TNF production following each round of E0771
Oncology April 28,2024
Molecular subtypes of advanced kidney cancer matter for treatment response

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the
Oncology April 28,2024
Molecular subtypes of advanced kidney cancer matter for treatment response

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the
Oncology April 28,2024
New insight into combating drug-resistant prostate cancer

New insight into combating drug-resistant prostate cancer

byUniversity of Eastern FinlandCredit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad1126Recent research from the University of Eastern Finland sheds light on the significance of
Oncology April 28,2024
New insight into combating drug-resistant prostate cancer

New insight into combating drug-resistant prostate cancer

byUniversity of Eastern FinlandCredit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad1126Recent research from the University of Eastern Finland sheds light on the significance of
Oncology April 28,2024
Newly discovered mechanism helps tumor cells evade the immune system early on

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache
Oncology April 28,2024
Newly discovered mechanism helps tumor cells evade the immune system early on

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache
Oncology April 28,2024
Adding vaccine to immunotherapy for liver cancer shows promise in early trial

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh
Oncology April 28,2024
Adding vaccine to immunotherapy for liver cancer shows promise in early trial

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh
Oncology April 28,2024
Access to genomic medicine illustrates precision medicine's delicate future

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss
Oncology April 28,2024
Access to genomic medicine illustrates precision medicine's delicate future

Access to genomic medicine illustrates precision medicine's delicate future

byOsaka UniversityTest Availability of Multigene Panel Tests in Japan and SwitzerlandCC BY, Nakasato K, Manz C and Kato K (2024) Access, autonomy, and affordability: ethical and human rights iss
Oncology April 28,2024
Few cancer survivors fully adherent to ACS nutrition and physical activity guidelines

Few cancer survivors fully adherent to ACS nutrition and physical activity guidelines

by Elana GotkineOnly 4% of cancer survivors are fully adherent to current American Cancer Society (ACS) nutrition and physical activity guidelines, according to a studypublishedonline Apri
Oncology April 28,2024
Few cancer survivors fully adherent to ACS nutrition and physical activity guidelines

Few cancer survivors fully adherent to ACS nutrition and physical activity guidelines

by Elana GotkineOnly 4% of cancer survivors are fully adherent to current American Cancer Society (ACS) nutrition and physical activity guidelines, according to a studypublishedonline Apri
Oncology April 28,2024
Softer tumors fuel more aggressive spread of triple-negative breast cancer, research shows

Softer tumors fuel more aggressive spread of triple-negative breast cancer, research shows

byGarvan Institute of Medical ResearchFluorescent image of cancer cells (cell nuclei in blue) stockpiling lipids in the form of lipid droplets (in red). The researchers showed these lipid drople
Oncology April 28,2024
Softer tumors fuel more aggressive spread of triple-negative breast cancer, research shows

Softer tumors fuel more aggressive spread of triple-negative breast cancer, research shows

byGarvan Institute of Medical ResearchFluorescent image of cancer cells (cell nuclei in blue) stockpiling lipids in the form of lipid droplets (in red). The researchers showed these lipid drople
Oncology April 28,2024
Family-focused interventions for African Americans with cancer

Family-focused interventions for African Americans with cancer

by Amy Cherry,University of DelawareCredit: Pixabay/CC0 Public DomainThe moment you're told the dreaded words: "You have cancer," your life changes forever. A parent diagnosed with
Oncology April 28,2024
Family-focused interventions for African Americans with cancer

Family-focused interventions for African Americans with cancer

by Amy Cherry,University of DelawareCredit: Pixabay/CC0 Public DomainThe moment you're told the dreaded words: "You have cancer," your life changes forever. A parent diagnosed with
Oncology April 28,2024
New treatment approach shows promise in hard-to-treat pediatric cancers

New treatment approach shows promise in hard-to-treat pediatric cancers

byFlorida International UniversityResearcher Diana Azzam and Logan Jenner, a participant in her clinical study, in the Azzam Lab at Florida International University. Credit: Florida Internationa
Oncology April 28,2024
New treatment approach shows promise in hard-to-treat pediatric cancers

New treatment approach shows promise in hard-to-treat pediatric cancers

byFlorida International UniversityResearcher Diana Azzam and Logan Jenner, a participant in her clinical study, in the Azzam Lab at Florida International University. Credit: Florida Internationa
Oncology April 28,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com